Natco Pharma Ltd Board of Directors

Home

Insights

Board of Directors

₹ 5.7 Cr

Volume transacted

37.5 K

stocks traded

Last Updated time: 19 Sep 9.00 AM

Board of Directors

Name	Designation

V C Nannapaneni	Chairman & Managing Director
Rajeev Nannapaneni	Vice Chairman & CEO
PSRK Prasad	Vice President & Director
D Linga Rao	President & Director
Pavan Bhat	Vice President & Director

name	designation
V C Nannapaneni	Chairman & Managing Director
Rajeev Nannapaneni	Vice Chairman & CEO
PSRK Prasad	Vice President & Director
D Linga Rao	President & Director
Pavan Bhat	Vice President & Director

Open Demat Account

Enter your mobile no. to continue

+91

*By signing up you agree to our terms & conditions

50 Years

of Trust & Legacy

₹0 AMC

for First Year

₹0 Brokerage

on Delivery, Intraday, Currency and NSE F&O

Key Highlights

V C Nannapaneni joins the board as Chairman & Managing Director, in a new position in 2024. This addition introduces a dedicated role focused on the company’s day-to-day operations and strategic implementation.
Rajeev Nannapaneni joins the board as Vice Chairman & CEO, in a new position in 2024. This addition introduces a dedicated role focused on the company’s day-to-day operations and strategic implementation.
PSRK Prasad joins the board as Vice President & Director, in a new position in 2024. This addition introduces a dedicated role focused on the company’s day-to-day operations and strategic implementation.
D Linga Rao joins the board as President & Director, in a new position in 2024. This addition introduces a dedicated role focused on the company’s day-to-day operations and strategic implementation.
Pavan Bhat joins the board as Vice President & Director, in a new position in 2024. This addition introduces a dedicated role focused on the company’s day-to-day operations and strategic implementation.

Natco Pharma Ltd

NSE: NATCOPHARM

PRICE

Last updated:

Last Ten Days Share Price

Date	Price	Day Open	Day High	Day Low

19 Sep 2024	1515.15	1563.9	1563.9	1490.65
18 Sep 2024	1540.25	1560	1566.75	1520.05
17 Sep 2024	1561.55	1577	1583.85	1557.5
16 Sep 2024	1577	1585.85	1595	1557.9
13 Sep 2024	1582.9	1609.55	1618.35	1573
12 Sep 2024	1592.6	1596.3	1638.35	1565.65
11 Sep 2024	1592	1546.15	1622.6	1546.15
10 Sep 2024	1545.5	1564.45	1585	1535.45
09 Sep 2024	1545.75	1560.05	1561.55	1524.45
06 Sep 2024	1560	1560.2	1577.85	1532.35

Date	Price
19 Sep 2024	1515.15
18 Sep 2024	1540.25
17 Sep 2024	1561.55
16 Sep 2024	1577
13 Sep 2024	1582.9
12 Sep 2024	1592.6
11 Sep 2024	1592
10 Sep 2024	1545.5
09 Sep 2024	1545.75
06 Sep 2024	1560

Company Fundamentals for Natco Pharma Ltd

Market Cap

₹ 27,137 Cr

EPS

₹ 91.4

P/E Ratio (TTM) *

16.6

P/B Ratio (TTM) *

4.6

Day’s High *

1563.9

Day’s Low

₹ 1490.65

DTE *

0.1

ROE *

23.7

52 Week High

₹ 1638.35

52 Week Low

₹ 725.0

ROCE *

27.2

PRICE

The current market price or CMP refers to the price at which the securities are trading in the share market. Current price in Over-the-counter costs: The following current price depends upon the bid price & the asking price when a financial asset is sold over-the-counter(OTC). Current Price in Bond Market: The current price of a bond is determined by measuring the actual interest rate against the bid-related interest rate. The par or the face value is then calculated to represent the remaining interest payments due which occur before the maturity of the bond.

Share price Over Time

Monitoring Natco Pharma Ltd share price can help you stay informed about potential market shifts and opportunities. *All values are in Rupees.

Natco Pharma Ltd News Hub

Natco Pharma Ltd slips for fifth straight session

Natco Pharma Ltd dropped for a fifth straight session today. The stock is quoting at Rs 15...

19 Sep 202413:35

Natco Pharma invests USD 8 mn in bio-tech firm eGenesis

Natco Pharma announced that its wholly owned Canadian subsidiary, Natco Pharma (Canada) In...

04 Sep 202412:07

Natco Pharma Canada arm invests $8 mln in eGenesis

eGenesis is engaged in using its multiplex gene editing and genome engineering platform to...

04 Sep 202412:01

Natco Pharma Ltd spurts 1.25%, up for third straight session

Natco Pharma Ltd rose for a third straight session today. The stock is quoting at Rs 1570....

23 Aug 202413:05

Natco Pharma schedules AGM

Natco Pharma announced that the 41th Annual General Meeting (AGM) of the company will be h...

12 Aug 202416:48

Board of Natco Pharma recommends dividend

Natco Pharma announced that the Board of Directors of the Company at its meeting held on 1...

12 Aug 202415:57

Document

Annual Reports

Annual Report 2023

Credit Ratings

Credit Report 2023

Concalls

June 2024

May 2024

Feb 2024

Nov 2023

Aug 2023

June 2023

Feb 2023

Nov 2022

Aug 2022

June 2022

Feb 2022

Nov 2021

Aug 2021

July 2021

Feb 2021

Nov 2020

Aug 2020

July 2020

Feb 2020

June 2024

May 2024

Feb 2024

Nov 2023

Aug 2023

June 2023

Feb 2023

Nov 2022

Aug 2022

June 2022

Feb 2022

Nov 2021

Aug 2021

July 2021

Feb 2021

Nov 2020

Aug 2020

July 2020

Feb 2020

Popular Search

Natco Pharma Ltd share holding pattern

Natco Pharma Ltd market cap

Natco Pharma Ltd share price history

Natco Pharma Ltd isin code

Sun Pharmaceuticals Industries Ltd board of directors

Divis Laboratories Ltd board of directors

Cipla Ltd board of directors

Torrent Pharmaceuticals Ltd board of directors

Dr Reddys Laboratories Ltd board of directors

Zydus Lifesciences Ltd board of directors

Lupin Ltd board of directors

Mankind Pharma Ltd board of directors

Aurobindo Pharma Ltd board of directors

Alkem Laboratories Ltd board of directors

FAQs for Board of Directors of Natco Pharma Ltd

How are members of Natco Pharma Ltd Board of Directors selected?

Members of the Natco Pharma Ltd Board of Directors are typically selected based on their expertise, experience, and alignment with Natco Pharma Ltd’s strategic goals. Appointments are made by the nomination and remuneration committee and approved by shareholders. However, the selection process does vary from company to company.

Can shareholders interact with the Natco Pharma Ltd Board of Directors?

Shareholders can interact with the Natco Pharma Ltd Board of Directors during the Annual General Meeting (AGM) and through formal communications or queries submitted to the company wherein they have the opportunity to ask questions and provide feedback on the business. Please note different companies have different protocols for shareholders who want to meet the Board of Directors.

How often does the Natco Pharma Ltd Board of Directors meet?

The Natco Pharma Ltd Board of Directors typically meets quarterly. However, special meetings may be summoned as needed to address urgent matters. The frequency can vary depending on business needs and regulatory requirements to ensure ongoing oversight and strategic guidance for the company. A scheduled meeting among the Board of Directors may vary from company to company.

What are the responsibilities of the Natco Pharma Ltd Board of Directors?

The Natco Pharma Ltd Board of Directors is responsible for setting strategic goals, overseeing company performance, ensuring effective governance, and safeguarding shareholder interests. They provide high-level guidance on corporate policies and risk management. Additionally, they appoint and evaluate senior management and ensure compliance with legal and regulatory requirements. Please note the roles and responsibilities of the Board of Directors may be different from company to company.

Who are the current members of the Board of Directors at Natco Pharma Ltd?

The current Board of Directors at Natco Pharma Ltd includes V C Nannapaneni( Chairman & Managing Director) ,Rajeev Nannapaneni( Vice Chairman & CEO) ,PSRK Prasad( Vice President & Director) ,D Linga Rao( President & Director) ,Pavan Bhat( Vice President & Director) . The full list can be found on Natco Pharma Ltd’s official website or recent corporate filings.

Disclaimer: This information provided above is for informational purposes only and does not constitute investment advice. We use third-party data and recommend conducting thorough research and consulting a certified financial advisor before making investment decisions. We do not endorse specific stocks. Make decisions based on your own research and professional guidance.

Unlimited trading at just

~~Rs. 399~~

Rs. 199*